Skip to main content

Biological variability of cell-free DNA in healthy females at rest within a short time course.

Brodbeck K, Schick S, Bayer B, Anslinger K, Krüger K, Mayer Z, Holdenrieder S, Peldschus S

Publication: Int J Legal Med (2020) • Vol 134 • Page 911-919PMID: 31900625View on PubMed

Purpose

The purpose of this paper was to investigate the short-term variability in cell-free DNA (cfDNA), aspartate aminotransferase (AST), and creatinine kinase (CK) levels by comparing levels in plasma obtained at defined intervals over the course of 75 min. The effects of blood pressure, hematocrit, pulse, or reported level of anxiety or pain at collection time or average frequency of physical exercise on cfDNA concentration were also investigated.

Conclusion

cfDNA, AST, and CK levels varied among the timepoints in all patients but the only significant difference from initial levels was lower AST in the specimens collected after 10 min. cfDNA was not significantly affected by blood pressure, hematocrit, pulse, or reported level of anxiety or pain at collection time or average frequency of physical exercise reported by the patient.

Studies (1)

Purpose

The purpose of this study was to investigate the short-term variability in cfDNA, AST, and CK levels by comparing levels in plasma obtained at defined intervals over the course of 75 min. The effects of blood pressure, hematocrit, pulse, and reported level of anxiety or pain at collection time or average frequency of physical exercise on cfDNA concentration were also investigated. EDTA blood was obtained by peripheral intravenous catheter from 14 healthy females immediately after venipuncture and then again for 2-4 additional timepoints over the course of 75 min (at 5, 10, 15, 20, 30, 40, 45, 60, or 75 min). Plasma was obtained by centrifugation at 1600 x g for 10 min followed by recentrifugation of the plasma at 4500 x g for 10 min within 2 h of blood draw. Plasma aliquots were frozen at -80°C for 9 months before DNA isolation using the Norgen Plasma/Serum Circulating DNA Purification Mini Kit. DNA concentration was evaluated using the real-time qRT-PCR based Quantifiler Trio DNA Quantification Kit. CK and AST levels were evaluated in blood specimens obtained at 0, 5, 10, 15 (only some), 20, 30, and 40 min using a Cobas c 501 system.

Summary of Findings

cfDNA concentration was quantifiable in 61 of 62 specimens with a median concentration of 1.4 ng/mL. The highest median cfDNA concentration was in the initial collection and the lowest at 20 min but the difference was not significant. Importantly, while the cfDNA concentrations in plasma from individual patients fluctuated 11.8-38.5% among the timepoints, there was no trend observed in the direction of the fluctuations. Fold-change in cfDNA concentration ranged from 0.4-1.6. cfDNA was not significantly affected by blood pressure, hematocrit, pulse, or reported level of anxiety or pain at collection time or average frequency of physical exercise reported by the patient. Fold-changes of 0.7-1.1 in CK levels and 0.6-1.2 in AST levels were found over the time-course but the only significant difference from the initial collection was lower AST levels in the specimen collected after 10 min (P=0.03).

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
  • Platforms

    DNAReal-time qPCR
    ProteinClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionBlood pressure
    Diastolic median 73 mmHg (IQR of 68–80)
    Systolic median 120 mmHg (IQR of 110–128)
    PreaquisitionDiagnosis/ patient condition
    Hematocrit 39-41
    Nervousness score (range not stated)
    Pain associated with cannula (range not stated)
    Pain associated with cannula (scores range not stated)
    Pulse 50-88
    Biospecimen AcquisitionTime of biospecimen collection
    0 min after venipuncture
    10 min after venipuncture
    15 min after venipuncture
    20 min after venipuncture
    30 min after venipuncture
    40 min after venipuncture
    45 min after venipuncture
    5 min after venipuncture
    60 min after venipuncture
    75 min after venipuncture
    Biospecimen Aliquots and ComponentsAliquot sequential collection
    1st collection
    2nd collection
    3rd collection
    4th collection
    5th collection